Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. - Test2 - elhamkhani - TriplyDB

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

http://www.wikidata.org/entity/Q30584496

about

Surveillance for Hepatocellular Carcinoma in Patients with NASH Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective Alcohol and hepatocellular carcinoma: a review and a point of view NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535 Gender Differences in Adipocyte Metabolism and Liver Cancer Progression Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update.High cancer mortality for US-born Latinos: evidence from California and Texas Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk Hepatocellular carcinoma: From diagnosis to treatment.Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway Pesticide exposure and hepatocellular carcinoma risk: A case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data.Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Cancers attributable to infections among adults with HIV in the United States.The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030 Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge.Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects.The evolving epidemiology of hepatocellular carcinoma: a global perspective.International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based study Disparities in liver cancer occurrence in the United States by race/ethnicity and state.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Nonalcoholic fatty liver disease in Asia: emerging perspectives.

P2860

Q26747428-8F229A8F-DB4F-48DE-B336-6F974E325FD4 Q26767217-5A2C2C0E-7D66-4CA6-96EF-7AB10F85F6E3 Q26860623-821AE248-91C8-4FE0-9114-B77D6ECDD556 Q27001052-4D3DB966-960B-4D6B-91E5-B59A73008948 Q27025083-7CA1E1A3-DBFC-4D85-B7D8-27799A40C802 Q27324314-89FA926B-D29F-4CCE-9204-AA0DDC053AD6 Q28078472-FFE67B37-7D58-4039-9D94-063A9737EE2E Q30234736-9C5B80DE-6639-4EAE-BC08-F3A3E9E19DB7 Q30746254-44139DD6-61E7-400B-9A3B-C338CF0D9319 Q33734116-7D4FBC8E-3588-44E9-836C-4B6DC3E96F2C Q33892881-3AB6F4BF-B8B5-4641-B4D4-20DF6F2CA474 Q34255487-A24C6FDA-3CBD-4BB9-B94D-4ED0D0217183 Q34765518-DFD290F3-4E68-4D69-97E8-CA061F993905 Q35047746-99098D32-7B40-4AC1-BA0D-24C6E1C189AF Q35152907-491C0B9C-B4EE-42F4-81DA-42D43290CE68 Q35188136-EDA7A868-90F1-4BBB-92D0-25ACCFA66EA5 Q35234688-23C27E4C-3678-4838-907E-15EF29F0EC26 Q35649664-107B2B2E-CEF1-415E-8357-385A486DAB1A Q35668716-91FE25B8-7AE7-477B-B2D5-268DA4AA57D0 Q35781420-C0B75A1B-6F5A-458C-B3F2-4C71AD8A60DC Q35801608-1D33C43B-7CEF-43AC-94FF-63A417188A53 Q36064661-9849CAD9-EBE7-4E5B-85D0-08187AE3EDEE Q36151682-93297B36-ECDB-4D82-8821-9F9697500016 Q36199751-A3C907ED-C06B-4F30-98F1-1F9E0CFD050B Q36259445-7AC0EAAE-97F7-4F49-A5C0-D90F9649342A Q36540674-4FA23F0F-8954-4A5B-9BEF-84E8D798485C Q36652018-A60AB5B1-B07D-45D8-B609-84F1D14871C5 Q37137944-23A75CAE-855F-4EB6-BEEB-8AA9B94D39B5 Q37362541-2E9A51BD-67C6-4317-87DF-78C7BE50DC1E Q37432586-B16EB243-8DBB-42F1-81AA-E307BC1C86EB Q37496567-3BA30148-FF09-4E62-A81A-E90B247495CE Q37608627-18BF3DE3-6EC1-421F-942F-0B4A503A326F Q37698565-9D01423F-F512-4318-BF2D-159116939751 Q38231581-4D4670A8-7ADE-4086-8C1D-D20651BC63D8 Q38397998-64D30C8A-BABE-41A9-81B8-7D3FF2B8C734 Q38407646-FF610A8A-2C65-446C-B97C-B53B3DB493D4 Q38640503-8429C8DB-7774-4223-A2C8-D0BBF8ABEA40 Q38741005-EB682ECB-CB81-46DE-AA0B-DDE342859173 Q38752520-24646174-0150-4F81-83C3-46D0910C9E5A Q38956717-F30D01E7-AEA7-4283-8D0A-776FC1D04BDE

P2860

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

http://www.wikidata.org/entity/Q30584496

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Population-attributable fracti ...... arcinoma in the United States.

@ast

Population-attributable fracti ...... arcinoma in the United States.

@en

type

label

Population-attributable fracti ...... arcinoma in the United States.

@ast

Population-attributable fracti ...... arcinoma in the United States.

@en

prefLabel

Population-attributable fracti ...... arcinoma in the United States.

@ast

Population-attributable fracti ...... arcinoma in the United States.

@en

P1433

Q30584496-F2FD10D7-99E2-46B9-AE56-2FB2B02CB0C3

P1476

Q30584496-C2AE2C23-8AE5-428E-A200-9B78E4CF74C5

P2093

Q30584496-11741A2B-392F-433D-BD36-256550ECF027

Q30584496-228529AE-0ADB-4E1F-BA93-988969C8F640

Q30584496-4538C0EE-3310-4BBC-96E5-A0BE0D1B9F9A

Q30584496-50EB07F3-CE59-40D0-A043-1B8BADA78CB5

Q30584496-A1A6FABC-35A7-4110-8BA3-0246C18CFA43

Q30584496-CDC7996D-B6E3-424F-9D3F-532928049FF4

P2860

Q30584496-0749BE86-CC56-4F9E-87F5-744FB2F4ADF6

Q30584496-0968687E-3B7B-4237-9A41-98AAC49E517F

Q30584496-1A78287F-26EB-47C6-8A7C-927897D133B3

Q30584496-22D9E9D8-5DFB-42CD-892A-71548E778030

Q30584496-2C11AA5E-F81E-45A5-8E14-75AB32D5AA68

Q30584496-2EE29F06-81AA-45A7-B210-7A9E739BCFC2

Q30584496-2F33675C-CE85-454D-B953-120189E14E97

Q30584496-47697877-011F-4BC5-BCA3-87E9AACC9980

Q30584496-4E35CF2A-FA3E-43B0-8918-54900A5CA1EE

Q30584496-576B3F42-EC28-4637-B245-3013BB3E4570

P304

Q30584496-AACF83E0-E325-4585-967D-CD21BF67B7B3

P31

Q30584496-F3F1FB70-7AE1-4FF7-9AA9-68644BD575DD

P356

Q30584496-A5B75170-6576-46A2-A52C-7E879CFEA2DC

P407

Q30584496-668AC73C-B43F-4E48-9E41-A22FE6EF2E60

P433

Q30584496-2450A7F6-9ABE-49BF-AAB6-5094F7BE25F8

P478

Q30584496-08BEF19B-DBEE-4ED7-9799-68D648DF4C4B

P50

Q30584496-6B60823A-EE59-4C40-84BA-4EB1CAE91059

P577

Q30584496-18DCF971-CFEE-4EDC-AD18-355991E397B1

P5875

Q30584496-21473843-B814-4B2C-97C1-5CC6DDAFA104

P698

Q30584496-5B9F5D76-D3C3-4BAD-8EEF-E90386673AE4

P921

Q30584496-4CCE83C7-BE8F-41BD-98D8-8C1FE572A97B

P932

Q30584496-B67B388B-A00B-4E4A-84BC-901853C1EDE8

P356

P1433

The American Journal of Gastroenterology

P1476

Population-attributable fracti ...... arcinoma in the United States.

@en

P2093

Barry I Graubard

http://www.w3.org/2001/XMLSchema#string

Hashem B El-Serag

http://www.w3.org/2001/XMLSchema#string

Jessica A Davila

http://www.w3.org/2001/XMLSchema#string

Katherine A McGlynn

http://www.w3.org/2001/XMLSchema#string

Sabah Quraishi

http://www.w3.org/2001/XMLSchema#string

Tania M Welzel

http://www.w3.org/2001/XMLSchema#string

P2860

Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study

Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy

The global epidemiology of hepatocellular carcinoma: present and future

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

Tobacco smoke and involuntary smoking

Primary liver cancer: worldwide incidence and trends

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.

P304

1314-1321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2013.160

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237097314

http://www.w3.org/2001/XMLSchema#string

P698

23752878

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

4105976

http://www.w3.org/2001/XMLSchema#string